Find uplifting stories about heroes, innovations, and solutions
13054 results for "weight loss science"
A new weight-loss pill from AstraZeneca helped trial participants lose nearly 12% of their body weight in just nine months, offering fresh hope in the race to make weight management easier. The tablet could soon give doctors and patients another powerful tool in fighting obesity.
A breakthrough study shows the diabetes drug semaglutide helps older adults lose significant weight safely while improving heart health. Nearly half of participants over 65 achieved at least 15% weight loss in just over a year.
Scientists are testing a breakthrough obesity treatment that helps people lose up to a third of their body weight without sacrificing muscle mass. The triple-action drug retatrutide could solve one of the biggest problems with current weight-loss medications.
%2Fhttps%3A%2F%2Ftf-cmsv2-smithsonianmag-media.s3.amazonaws.com%2Ffiler_public%2Ff8%2Ff8%2Ff8f86afc-d21d-40cc-86c9-e212d1e51222%2Fleslie_leinwand_snake_research_0181.jpg)
Scientists discovered an appetite-suppressing molecule in python blood that helped obese mice lose 9% of their body weight without the stomach problems that plague current weight-loss drugs. This breakthrough could lead to a new generation of treatments inspired by nature's most extreme fasters.
Danish scientists discovered that losing weight doesn't just shrink fat cells—it actually helps regenerate healthier fat tissue. The breakthrough research shows that even modest weight loss can reverse obesity-related inflammation and restore fat tissue to a state resembling lean, healthy individuals.
Millions of Americans have lost significant weight using GLP-1 medications like Ozempic and Wegovy, but keeping it off requires a smart, sustainable plan. Here's the hopeful science behind maintaining your success.
People using GLP-1 weight loss medications may not need weekly injections forever. A new study shows many patients maintain their weight loss while spacing out doses to every two or even six weeks.
NIH researchers have discovered why popular weight loss drugs like Ozempic eventually stop working as well, and they've found a potential way to extend their effectiveness. The breakthrough could help millions push past frustrating plateaus.
Postmenopausal women combining hormone therapy with a popular weight loss drug lost 35% more weight than those taking the medication alone. The finding could transform how millions of women manage weight gain after menopause.
New research challenges concerns that popular GLP-1 medications like Wegovy and Zepbound cause excessive muscle loss. The findings offer reassurance to millions considering or using these breakthrough weight-loss treatments.
New real-world data shows many patients who stop taking popular weight loss drugs like Wegovy and Zepbound don't quickly regain the weight they lost. The findings challenge earlier concerns that the benefits disappear when treatment ends.
A new obesity treatment from pharmaceutical company Boehringer has shown promising results, helping patients lose an average of 16.6% of their body weight in clinical trials. The breakthrough adds another tool to the growing arsenal of effective weight loss medications changing lives worldwide.
A tiny molecule discovered using AI mimics Ozempic's weight loss effects without the nausea, constipation, or muscle loss. Animal studies show the peptide targets only the brain's appetite center, not the entire digestive system.
A promising triple-action medication could help people lose weight without sacrificing muscle. Retatrutide shows potential for safer weight loss with fewer side effects than earlier medications.
Researchers have created the first sex-specific brain map showing where popular weight-loss drugs like semaglutide work differently in females versus males. This breakthrough could explain why women often respond better to these treatments and pave the way for more personalized medicine.
A new experimental obesity treatment targeting three hormones has shown significant weight loss in early testing. The "triple-G" drug from Kailera offers fresh hope in the rapidly expanding field of weight management medicine.
A new diabetes treatment from Eli Lilly helped patients lose 15% of their body weight while improving blood sugar control, potentially becoming the most effective weight loss diabetes drug yet. The results offer hope for millions who struggle to shed pounds while managing their condition.
Two major clinical trials show people can maintain their weight loss by switching to lower doses or once-daily pills after initial treatment. The findings offer hope for tackling one of obesity care's biggest challenges: keeping weight off after losing it.
Scientists discovered that two genes can help predict who will lose weight on popular obesity medications and who might experience side effects. The breakthrough could personalize treatment for millions seeking help with weight loss.
People taking weight loss drugs like Wegovy are successfully maintaining their results by spacing out injections to every two weeks instead of weekly. A new study shows most patients kept the weight off and their health improvements without weekly shots.
Showing 20 of 13054